ResearcherCancer Research UK Scotland InstituteActive in the last 2 years
Sigrid K. Fey
Matched on ORCID iD 0009-0007-3667-513X; OpenAlex author ID A5047864584. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition. Co-author DOI 10.1158/0008-5472.can-23-2709↗
- Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition. Co-author DOI 10.1158/0008-5472.can-20-2496↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jennifer P. Morton · 2 shared papers, 2021–2025 · strength 0.29
- Paper KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic… DOI 10.1158/0008-5472.can-23-2709↗
- Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition. DOI 10.1158/0008-5472.can-20-2496↗
- Owen James Sansom · 2 shared papers, 2021–2025 · strength 0.29
- Paper KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic… DOI 10.1158/0008-5472.can-23-2709↗
- Paper Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition. DOI 10.1158/0008-5472.can-20-2496↗
- Joanna L. Birch · 1 shared paper, 2025 · strength 0.20
- Dale M. Watt · 1 shared paper, 2025 · strength 0.20
- Simon T. Barry · 1 shared paper, 2025 · strength 0.20
- Kathy McLay · 1 shared paper, 2025 · strength 0.20
- David Kuang-Fu Chang · 1 shared paper, 2025 · strength 0.20
- David Goldstein · 1 shared paper, 2021 · strength 0.08
- Val Gebski · 1 shared paper, 2021 · strength 0.08
- Joshua A. McCarroll · 1 shared paper, 2021 · strength 0.08
- Angela S. Y. Chou · 1 shared paper, 2021 · strength 0.08
- Thomas R. Cox · 1 shared paper, 2021 · strength 0.08
- Nigel A. Turner · 1 shared paper, 2021 · strength 0.08
- Amber L. Johns · 1 shared paper, 2021 · strength 0.08
- Mert Erkan · 1 shared paper, 2021 · strength 0.08
- Koroush Shahsavar Haghighi · 1 shared paper, 2021 · strength 0.08
- Marina Pajic · 1 shared paper, 2021 · strength 0.08
- Phoebe A. Phillips · 1 shared paper, 2021 · strength 0.08
- Jie Liu · 1 shared paper, 2021 · strength 0.08
- George Sharbeen · 1 shared paper, 2021 · strength 0.08
- Anthony James Gill · 1 shared paper, 2021 · strength 0.08
- John Kokkinos · 1 shared paper, 2021 · strength 0.08
- Minoti Vivek Apte · 1 shared paper, 2021 · strength 0.08
- Jessica L. Chitty · 1 shared paper, 2021 · strength 0.08
- Brooke Pereira · 1 shared paper, 2021 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.